Krammer Julia, Stepniewski Kathrin, Kaiser Clemens G, Brade Joachim, Riffel Philipp, Schoenberg Stefan O, Wasser Klaus
Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Anticancer Res. 2017 Sep;37(9):5255-5261. doi: 10.21873/anticanres.11950.
This retrospective study was initiated to determine the diagnostic value of additional preoperative breast tomosynthesis (DBT) for breast cancer staging in dense breasts.
Sixty-six patients (69 breasts) with findings of American College of Radiology category 3 or 4 with Breast Imaging Reporting and Data System 5, 6 or 0 were included. All patients underwent digital mammography and additional DBT.
A total of 40/69 (58%) cancers were detected on both mammography and DBT, 23 (33.3%) were only seen on DBT (p=0.0001); 6/69 (8.7%) carcinomas were not detected by either method, of which three were invasive lobular carcinomas. Sensitivity for multifocal/multicentric disease was significantly higher on DBT (12/19, 63.2%) compared to mammography (4/19, 21.1%) (p=0.02), specificity was comparable (96.0% vs. 90.0%). Multifocal/multicentric disease was not detected on mammography nor DBT in 7/19 (36.8%) patients, including three invasive lobular carcinomas.
DBT may significantly improve preoperative breast cancer staging in patients with dense breasts compared to conventional mammography alone. Nevertheless, limitations have to be expected in the case of invasive lobular carcinoma.
开展这项回顾性研究以确定额外的术前乳腺断层合成(DBT)对致密型乳腺中乳腺癌分期的诊断价值。
纳入66例患者(69个乳房),其美国放射学会(ACR)影像报告和数据系统(BI-RADS)分类为3或4类,且BI-RADS分级为5、6或0级。所有患者均接受了数字化乳腺钼靶检查及额外的DBT检查。
在乳腺钼靶检查和DBT检查中均检测到40/69(58%)例癌症,23例(33.3%)仅在DBT检查中被发现(p = 0.0001);6/69(8.7%)例癌症两种检查方法均未检测到,其中3例为浸润性小叶癌。DBT对多灶性/多中心性疾病的敏感性(12/19,63.2%)显著高于乳腺钼靶检查(4/19,21.1%)(p = 0.02),特异性相当(96.0%对90.0%)。7/19(36.8%)例患者的多灶性/多中心性疾病在乳腺钼靶检查和DBT检查中均未被发现,其中包括3例浸润性小叶癌。
与单纯传统乳腺钼靶检查相比,DBT可能显著改善致密型乳腺患者的术前乳腺癌分期。然而,浸润性小叶癌患者仍可能存在局限性。